Q3 Financial Performance
Denver, Colorado–(Newsfile Corp. – November 10, 2024) – CBD of Denver (OTC Pink: CBDD) is pleased to report estimated third quarter 2024 revenue of $763,450.00 compared to an estimated $677,893.00 for the same period in 2023.
German Market Update
More than nine months have passed since the Cannabis Act (CannG) came into effect in Germany on April 1, 2024. The law aimed to curb the cannabis black market and provide adults with widespread access to unadulterated, high-quality cannabis. However, the situation in the German market remains unclear and has fallen far short of expectations. As of October 10, 2024, only 29 license applications have been approved nationwide, with the number of cannabis club applications being lower than anticipated due to bureaucratic uncertainties and economic challenges in the market.
Cannabis clubs continue to face significant bureaucratic hurdles and often unclear legal frameworks, complicating their establishment and operation. Additionally, the company is still awaiting approval for its Grow Hub business model in one of the German federal states. Approval decisions lie with the federal states and relevant district and state authorities-and to date, no federal state has approved such infrastructure models.
Spin-Off Update
Due to a lack of clarity in the German market, the timeline for a potential spin-off of Luxora Inc. has been extended. This decision allows CBD of Denver to reassess the business climate and strategic opportunities, ensuring that any future actions align with shareholder value and long-term growth objectives.
General Outlook
As CBD of Denver progresses into new sectors, the focus remains on delivering value to shareholders through a broad, adaptable strategy. The company is actively exploring growth opportunities and reinforcing its commitment to steady expansion. While margins remain thin, CBD of Denver continues its efforts in the CBD wholesale market, demonstrating its commitment to maintaining and growing this core business area. Shareholders can expect continued updates as CBD of Denver advances its multi-sector approach.
About CBD of Denver, Inc.
CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company’s team is dedicated to sourcing high-margin, innovative products that align with its values.
About LUXORA Inc.
LUXORA Inc. is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering infrastructure solutions and consulting tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.
For inquiries, please contact Investor Relations: investors@luxora-holding.com
For more information, please visit: www.luxora-holding.com
Follow Us: X | linkedin
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/229439
To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added…
eClinicalWorks and the AI medical scribe assist the 126-provider health center in completing documentation at…
INDIANAPOLIS, Nov. 22, 2024 /PRNewswire/ -- Health centers across the state of Indiana have joined…
SHENZHEN, China, Nov. 22, 2024 /PRNewswire/ -- The 19th Annual Meeting of the International Conference…
CAMBRIDGE, Mass., Nov. 22, 2024 /PRNewswire/ -- SurgiBox, a pioneer in ultra-portable, inflatable surgical environments…
FORT WORTH, Texas, Nov. 22, 2024 /PRNewswire/ -- ESHA, Inc ("ESHA") provide certain revenue cycle…